A cross-sectional study of COVID-19-related bullying in a sample of Lebanese adults: scale validation, correlates, and mediating effect of fear and anxiety.


Journal

BMC psychology
ISSN: 2050-7283
Titre abrégé: BMC Psychol
Pays: England
ID NLM: 101627676

Informations de publication

Date de publication:
08 Sep 2021
Historique:
received: 03 04 2021
accepted: 18 08 2021
entrez: 9 9 2021
pubmed: 10 9 2021
medline: 11 9 2021
Statut: epublish

Résumé

The COVID-19 pandemic has led to prolonged exposure to stress and anxiety, raising concerns about a large spectrum of psychological side effects. The primary objective of the study was to validate the COVID-19 Bullying Scale (CBS-11). The second objective was to explore factors associated with COVID-19-related bullying and evaluate the mediating effect of fear and anxiety between knowledge and COVID-19-related bullying. A cross-sectional online survey conducted between December 20, 2020, and January 5, 2021, recruited 405 Lebanese adults using a snowball sampling technique. The CBS-11, an 11-item tool specifically created for this study, was used to measure bullying behaviors towards COVID-19 patients. All items of the CBS-11 converged over a 1-factor solution with an eigenvalue over 1, accounting for a variance of 75.16%. The scale has a high Cronbach's alpha (.974), indicating excellent reliability. A positive correlation was found between the COVID-19 bullying scale and fear, anxiety, and stigma discrimination. The logistic regression showed that higher fear of COVID-19 (ORa = 1.04), a positive attitude toward COVID-19 preventive measures and hygiene recommendations (ORa = 1.18), higher stigma discrimination scores (ORa = 1.09), and having a health professional family member (ORa = 2.42) were significantly associated with bullying. Our main findings showed that the CBS-11 could be an efficient tool to measure bullying behaviors toward COVID-19 patients. Stigma discrimination and fear from COVID-19 were associated with higher bullying attitudes. Future prospective studies are needed to understand better the factors related to bullying among adults during a pandemic, such as COVID-19.

Sections du résumé

BACKGROUND BACKGROUND
The COVID-19 pandemic has led to prolonged exposure to stress and anxiety, raising concerns about a large spectrum of psychological side effects. The primary objective of the study was to validate the COVID-19 Bullying Scale (CBS-11). The second objective was to explore factors associated with COVID-19-related bullying and evaluate the mediating effect of fear and anxiety between knowledge and COVID-19-related bullying.
METHODS METHODS
A cross-sectional online survey conducted between December 20, 2020, and January 5, 2021, recruited 405 Lebanese adults using a snowball sampling technique. The CBS-11, an 11-item tool specifically created for this study, was used to measure bullying behaviors towards COVID-19 patients.
RESULTS RESULTS
All items of the CBS-11 converged over a 1-factor solution with an eigenvalue over 1, accounting for a variance of 75.16%. The scale has a high Cronbach's alpha (.974), indicating excellent reliability. A positive correlation was found between the COVID-19 bullying scale and fear, anxiety, and stigma discrimination. The logistic regression showed that higher fear of COVID-19 (ORa = 1.04), a positive attitude toward COVID-19 preventive measures and hygiene recommendations (ORa = 1.18), higher stigma discrimination scores (ORa = 1.09), and having a health professional family member (ORa = 2.42) were significantly associated with bullying.
CONCLUSION CONCLUSIONS
Our main findings showed that the CBS-11 could be an efficient tool to measure bullying behaviors toward COVID-19 patients. Stigma discrimination and fear from COVID-19 were associated with higher bullying attitudes. Future prospective studies are needed to understand better the factors related to bullying among adults during a pandemic, such as COVID-19.

Identifiants

pubmed: 34496963
doi: 10.1186/s40359-021-00643-1
pii: 10.1186/s40359-021-00643-1
pmc: PMC8425023
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

137

Informations de copyright

© 2021. The Author(s).

Références

Disaster Med Public Health Prep. 2019 Dec;13(5-6):989-994
pubmed: 31156079
Clin Infect Dis. 2020 Jul 28;71(15):732-739
pubmed: 32150618
Psychol Assess. 2013 Dec;25(4):1045-57
pubmed: 23730831
Nat Med. 2020 May;26(5):640-642
pubmed: 32273610
Int J Ment Health Addict. 2020 Mar 27;:1-9
pubmed: 32226353
Emerg Infect Dis. 2005 Nov;11(11):1767-9
pubmed: 16318735
Brain Sci. 2019 Jun 06;9(6):
pubmed: 31174384
Int J Ment Health Addict. 2020 May 16;:1-14
pubmed: 32427217
J Psychiatr Res. 2020 Oct;129:88-97
pubmed: 32623026
Lancet Child Adolesc Health. 2020 Aug;4(8):634-640
pubmed: 32540024
BMC Public Health. 2021 Feb 3;21(1):275
pubmed: 33535992
Am J Public Health. 2006 Mar;96(3):561-7
pubmed: 16449597
Int J Environ Res Public Health. 2020 Apr 29;17(9):
pubmed: 32365502
J Anxiety Disord. 2020 Apr;71:102211
pubmed: 32179380
Ann Acad Med Singap. 2004 Nov;33(6):743-8
pubmed: 15608831
Brain Behav Immun. 2020 Oct;89:531-542
pubmed: 32485289
J Adolesc. 2011 Feb;34(1):59-71
pubmed: 20202677
J Adolesc Health. 2014 Nov;55(5):602-11
pubmed: 25168105
Perspect Psychiatr Care. 2021 Jul;57(3):1212-1221
pubmed: 33135217
J Soc Psychol. 2021 Jul 4;161(4):466-476
pubmed: 33543673
Occup Med (Lond). 2006 Jun;56(4):226-31
pubmed: 16507600
PLoS One. 2020 Oct 9;15(10):e0239254
pubmed: 33035219
Diabetes Res Clin Pract. 2020 Aug;166:108344
pubmed: 32710997
Annu Rev Psychol. 2014;65:159-85
pubmed: 23937767
J Health Polit Policy Law. 2020 Dec 1;45(6):967-981
pubmed: 32464658
Data Brief. 2020 Jun 12;31:105855
pubmed: 32607405
Int J Adolesc Med Health. 2008 Apr-Jun;20(2):209-21
pubmed: 18714557
Dev Rev. 2018 Jun;48:178-200
pubmed: 30220766
J Affect Disord. 2019 Sep 1;256:54-61
pubmed: 31158716
J Anxiety Disord. 2020 Oct;75:102289
pubmed: 32853884
Int J Antimicrob Agents. 2020 May;55(5):105960
pubmed: 32251731
Saudi Med J. 2019 Jun;40(6):601-609
pubmed: 31219496
Psychol Assess. 2012 Mar;24(1):156-65
pubmed: 22250594
Clin Infect Dis. 2021 Feb 16;72(4):697-702
pubmed: 32544242
Child Dev. 1995 Jun;66(3):710-22
pubmed: 7789197
Comput Hum Behav Rep. 2020 Aug-Dec;2:100029
pubmed: 34235292
Viruses. 2020 Feb 25;12(3):
pubmed: 32106567
Bull World Health Organ. 2010 Jun;88(6):403
pubmed: 20539848
Medicine (Baltimore). 2020 Jul 24;99(30):e21279
pubmed: 32791708
Lancet Psychiatry. 2020 Sep;7(9):813-824
pubmed: 32682460
BMJ Open. 2020 Dec 30;10(12):e046620
pubmed: 33380488
Psychiatry Clin Neurosci. 2020 Oct;74(10):566-568
pubmed: 32779787
Aggress Behav. 2011 May-Jun;37(3):234-47
pubmed: 21404281
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32631833
Cochrane Database Syst Rev. 2020 Nov 20;11:CD006207
pubmed: 33215698
Int J Environ Res Public Health. 2020 Jun 02;17(11):
pubmed: 32498267
JAMA. 2001 Apr 25;285(16):2094-100
pubmed: 11311098
Soc Sci Med. 2009 Oct;69(8):1186-93
pubmed: 19713022
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):779-788
pubmed: 32526627
Death Stud. 2020;44(7):393-401
pubmed: 32299304
Health Serv Res. 2003 Dec;38(6 Pt 2):1645-717
pubmed: 14727793
Glob Ment Health (Camb). 2018 Jun 18;5:e22
pubmed: 29997894
BMC Pediatr. 2020 Nov 14;20(1):520
pubmed: 33187493
Psychiatry Res. 2018 Mar;261:94-101
pubmed: 29291479
Front Med (Lausanne). 2020 Aug 18;7:542
pubmed: 33015096
AIDS Behav. 2008 Sep;12(5):772-80
pubmed: 18080830
Bioimpacts. 2020;10(3):139-140
pubmed: 32793435
Res Nurs Health. 2001 Dec;24(6):518-29
pubmed: 11746080
Int J Ment Health Nurs. 2020 Jun;29(3):315-318
pubmed: 32277578
Emerg Infect Dis. 2020 Jul;26(7):1616-1618
pubmed: 32202993
J Community Health. 2021 Jun;46(3):457-470
pubmed: 32638198
Psychol Sci. 2017 Jun;28(6):808-821
pubmed: 28452573
Child Dev. 1996 Feb;67(1):70-88
pubmed: 8605835
Soc Sci Med. 1995 Aug;41(4):557-68
pubmed: 7481950
MDM Policy Pract. 2020 Apr 26;5(1):2381468320915239
pubmed: 32440569
Front Public Health. 2020 May 27;8:217
pubmed: 32574300
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
J Sch Health. 2010 Apr;80(4):193-9
pubmed: 20433645
Int J Environ Res Public Health. 2020 Apr 23;17(8):
pubmed: 32340349
AIDS Care. 2011 Nov;23(11):1448-55
pubmed: 22022851

Auteurs

Chadia Haddad (C)

Research Department, Psychiatric Hospital of the Cross, P.O. Box 60096, Jal Eddib, Lebanon. Chadia_9@hotmail.com.
INSERM, CH Esquirol Limoges, IRD, U1094 Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, GEIST, University of Limoges, Limoges, France. Chadia_9@hotmail.com.
INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon. Chadia_9@hotmail.com.

Hala Sacre (H)

INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon.

Sandrella Bou Malhab (S)

INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon.

Diana Malaeb (D)

INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon.
School of Pharmacy, Lebanese International University, Beirut, Lebanon.

Danielle Saadeh (D)

INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon.
Faculty of Public Health, Lebanese University, Beirut, Lebanon.

Christine Abou Tayeh (C)

INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon.

Pascale Salameh (P)

INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon.
Faculty of Pharmacy, Lebanese University, Beirut, Lebanon.
University of Nicosia Medical School, Nicosia, Cyprus.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH